Yake Biotechnology

CAR-T beyond cancer? Novartis and others say yes
EP Vantage
Mon, 06/19/23 - 10:19 am
CAR-T
Novartis
Cabaletta Bio
Cartesian Therapeutics
Bristol Myers Squibb
Gracell
Yake Biotechnology